Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 11, Issue 12, Pages 1511-1527Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612053764814
Keywords
AMPA receptors; depression; brain-derived neurotrophic factor; BDNF; neurogenesis; LY392098; LY404187; LY451646
Categories
Ask authors/readers for more resources
Depression affects a large percentage of the general population and can produce devastating consequences to affected individuals, families and society. Although the treatment of depression has been advanced by traditional antidepressants, improvements are needed across several dimensions (e.g., overall treatment efficacy, therapeutic onset time, and side effect profile). The alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor has an allosteric modulatory site(s) for which potent positive modulators (potentiators) have been designed. These compounds produce antidepressant-like effects in animal models, increase levels of brain-derived neurotrophic factor (BDNF) and engender neurogenesis in vivo. Although these effects are also produced by traditional antidepressants, AMPA receptor potentiators appear to produce their effects through a novel mechanism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available